Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603882'
s OCF Margin % Range Over the Past 10 Years
Min: 7.48 Med: 12.6 Max: 19.93
Current: 18.49
During the past 13 years, the highest OCF Margin % of Guangzhou Kingmed Diagnostics Group Co was 19.93%. The lowest was 7.48%. And the median was 12.60%.
SHSE:603882's OCF Margin % is ranked better than 73.4% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: 6.16
vs SHSE:603882: 18.49
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Kingmed Diagnostics Group Co OCF Margin % Chart
Guangzhou Kingmed Diagnostics Group Co Annual Data
SHSE:603882 vs TMO, DHR, NTRA: OCF Margin % Comparison
For the Diagnostics & Research subindustry, Guangzhou Kingmed Diagnostics Group Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Kingmed Diagnostics Group Co OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Guangzhou Kingmed Diagnostics Group Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Guangzhou Kingmed Diagnostics Group Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) has a OCF Margin % of 12.99% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors. This is near median its historical median of 12.60. Over the past decade, Guangzhou Kingmed Diagnostics Group Co's OCF Margin % has ranged from 7.48 to 19.93. According to the industry distribution chart, Guangzhou Kingmed Diagnostics Group Co ranks #54 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 26.6%.
Is Guangzhou Kingmed Diagnostics Group Co's OCF Margin % too high?
Guangzhou Kingmed Diagnostics Group Co's current OCF Margin % of 12.99% is near median its 10-year median of 12.60. Over the past 10 years, this metric has ranged from a low of 7.48 to a high of 19.93. The Medical Diagnostics & Research industry median OCF Margin % is 6.16. Guangzhou Kingmed Diagnostics Group Co's value of 12.99% is 110.9% above this industry median. Based on the distribution chart, Guangzhou Kingmed Diagnostics Group Co ranks #54 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Guangzhou Kingmed Diagnostics Group Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Kingmed Diagnostics Group Co's OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Guangzhou Kingmed Diagnostics Group Co ranks #54 out of 203 companies for OCF Margin %. This puts Guangzhou Kingmed Diagnostics Group Co in the upper half of its industry. The industry median OCF Margin % is 6.16. Guangzhou Kingmed Diagnostics Group Co's value of 12.99% is 110.9% above this benchmark. Historically, Guangzhou Kingmed Diagnostics Group Co's own OCF Margin % has ranged from 7.48 to 19.93 over the past decade. While the company's 10-year median is 12.60 vs. the industry median of 6.16, Guangzhou Kingmed Diagnostics Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 6.16, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Kingmed Diagnostics Group Co's current OCF Margin % of 12.99% is 110.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 6.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Kingmed Diagnostics Group Co's current OCF Margin % is 12.99%, which is near median its own 10-year median of 12.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Kingmed Diagnostics Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.43, compared to a current price of ¥26.70 — trading 6.1% below its estimated fair value. The current OCF Margin % is 12.99%, which is near median its 10-year median of 12.60 and 110.9% above the Medical Diagnostics & Research industry median of 6.16. Guangzhou Kingmed Diagnostics Group Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Guangzhou Kingmed Diagnostics Group Co (SHSE:603882), the current OCF Margin % is 12.99% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co stock appears to be undervalued.
The current stock price of ¥26.70 is trading 6.1% below its estimated GF Value™ of ¥28.43.
GuruFocus considers Guangzhou Kingmed Diagnostics Group Co to be Fairly Valued.
Key valuation signals for SHSE:603882:
OCF Margin %: 12.99% (near median its 10-year median of 12.60)
GF Value™: ¥28.43 vs. price of ¥26.70 (6.1% below fair value)
Industry Position: 110.9% above the Medical Diagnostics & Research median (#54 of 203)
No single metric tells the full story. See the SHSE:603882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
79GF Score
Get the complete analysis for SHSE:603882
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603882 has been successfully added to your 
